Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price
on Feb 6, 2025
Revance Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Cash & Equivalents | 58.59 | 137.33 | 108.97 | 110.62 | 333.56 | 171.16 | Upgrade
|
| Short-Term Investments | 125.49 | 116.59 | 231.74 | 114.45 | 102.95 | 118.96 | Upgrade
|
| Cash & Short-Term Investments | 184.08 | 253.92 | 340.71 | 225.07 | 436.51 | 290.12 | Upgrade
|
| Cash Growth | -38.69% | -25.47% | 51.38% | -48.44% | 50.46% | 65.01% | Upgrade
|
| Accounts Receivable | 48.26 | 27.68 | 11.34 | 3.35 | 1.86 | - | Upgrade
|
| Receivables | 48.26 | 27.68 | 11.34 | 3.35 | 1.86 | - | Upgrade
|
| Inventory | 85.21 | 45.58 | 18.33 | 10.15 | 5.88 | - | Upgrade
|
| Prepaid Expenses | 9.94 | 11.15 | 4.36 | 7.54 | 5.76 | 6.49 | Upgrade
|
| Restricted Cash | 0.47 | 0.55 | - | - | - | - | Upgrade
|
| Other Current Assets | 1.74 | - | - | - | - | - | Upgrade
|
| Total Current Assets | 329.69 | 338.87 | 374.73 | 246.12 | 450 | 296.6 | Upgrade
|
| Property, Plant & Equipment | 76.99 | 90.21 | 59.42 | 69 | 47.13 | 41.29 | Upgrade
|
| Goodwill | - | - | 77.18 | 146.96 | 146.96 | - | Upgrade
|
| Other Intangible Assets | 7.63 | 9.81 | 35.34 | 55.33 | 71.34 | - | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | 0.08 | - | Upgrade
|
| Other Long-Term Assets | 47.25 | 39.57 | 35.24 | 13.75 | 4.7 | 2.4 | Upgrade
|
| Total Assets | 461.56 | 478.45 | 581.9 | 531.16 | 720.22 | 340.29 | Upgrade
|
| Accounts Payable | 12.34 | 13.81 | 4.55 | 10.6 | 12.66 | 8.01 | Upgrade
|
| Accrued Expenses | 32.8 | 52.91 | 59.36 | 37.66 | 29.67 | 17.43 | Upgrade
|
| Current Portion of Long-Term Debt | 10.15 | 2.5 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 17.21 | 8.35 | 4.91 | 4.75 | 4.44 | 3.47 | Upgrade
|
| Current Unearned Revenue | 6.33 | 10.74 | 6.87 | 9.36 | 7.85 | 7.91 | Upgrade
|
| Other Current Liabilities | 1.22 | 0.92 | - | 4.92 | 6.35 | 4.16 | Upgrade
|
| Total Current Liabilities | 80.05 | 89.22 | 75.68 | 67.29 | 60.96 | 40.98 | Upgrade
|
| Long-Term Debt | 421.04 | 426.6 | 379.37 | 280.64 | 180.53 | - | Upgrade
|
| Long-Term Leases | 35.04 | 40.99 | 34.18 | 39.13 | 27.15 | 25.87 | Upgrade
|
| Long-Term Unearned Revenue | 85.55 | 70.42 | 78.58 | 74.15 | 77.29 | 47.95 | Upgrade
|
| Other Long-Term Liabilities | 2.91 | 2.84 | 1.49 | 1.49 | - | - | Upgrade
|
| Total Liabilities | 624.59 | 630.06 | 569.3 | 462.69 | 345.93 | 114.8 | Upgrade
|
| Common Stock | 0.11 | 0.09 | 0.08 | 0.07 | 0.07 | 0.05 | Upgrade
|
| Additional Paid-In Capital | 2,044 | 1,927 | 1,767 | 1,466 | 1,501 | 1,070 | Upgrade
|
| Retained Earnings | -2,207 | -2,078 | -1,754 | -1,398 | -1,126 | -844.2 | Upgrade
|
| Comprehensive Income & Other | 0.07 | 0.01 | -0.37 | -0.02 | - | 0 | Upgrade
|
| Total Common Equity | -163.03 | -151.6 | 12.6 | 68.47 | 374.29 | 225.49 | Upgrade
|
| Shareholders' Equity | -163.03 | -151.6 | 12.6 | 68.47 | 374.29 | 225.49 | Upgrade
|
| Total Liabilities & Equity | 461.56 | 478.45 | 581.9 | 531.16 | 720.22 | 340.29 | Upgrade
|
| Total Debt | 483.45 | 478.43 | 418.47 | 324.51 | 212.11 | 29.34 | Upgrade
|
| Net Cash (Debt) | -299.37 | -224.52 | -77.76 | -99.44 | 224.4 | 260.78 | Upgrade
|
| Net Cash Growth | - | - | - | - | -13.95% | 48.33% | Upgrade
|
| Net Cash Per Share | -3.09 | -2.65 | -1.07 | -1.47 | 3.87 | 6.00 | Upgrade
|
| Filing Date Shares Outstanding | 104.9 | 88.21 | 82.8 | 71.45 | 71.38 | 56.93 | Upgrade
|
| Total Common Shares Outstanding | 104.9 | 87.96 | 82.39 | 71.58 | 69.18 | 52.37 | Upgrade
|
| Working Capital | 249.64 | 249.64 | 299.05 | 178.83 | 389.04 | 255.62 | Upgrade
|
| Book Value Per Share | -1.55 | -1.72 | 0.15 | 0.96 | 5.41 | 4.31 | Upgrade
|
| Tangible Book Value | -170.66 | -161.41 | -99.92 | -133.83 | 155.98 | 225.49 | Upgrade
|
| Tangible Book Value Per Share | -1.63 | -1.84 | -1.21 | -1.87 | 2.25 | 4.31 | Upgrade
|
| Machinery | - | - | - | 25.73 | 23.12 | 21.82 | Upgrade
|
| Construction In Progress | - | - | - | 3.11 | 1.54 | 2.39 | Upgrade
|
| Leasehold Improvements | - | - | - | 7.48 | 5.97 | 5.37 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.